Correlation Between Cizzle Biotechnology and Mynaric AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cizzle Biotechnology and Mynaric AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cizzle Biotechnology and Mynaric AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cizzle Biotechnology Holdings and Mynaric AG, you can compare the effects of market volatilities on Cizzle Biotechnology and Mynaric AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cizzle Biotechnology with a short position of Mynaric AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cizzle Biotechnology and Mynaric AG.

Diversification Opportunities for Cizzle Biotechnology and Mynaric AG

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cizzle and Mynaric is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cizzle Biotechnology Holdings and Mynaric AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mynaric AG and Cizzle Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cizzle Biotechnology Holdings are associated (or correlated) with Mynaric AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mynaric AG has no effect on the direction of Cizzle Biotechnology i.e., Cizzle Biotechnology and Mynaric AG go up and down completely randomly.

Pair Corralation between Cizzle Biotechnology and Mynaric AG

Assuming the 90 days trading horizon Cizzle Biotechnology is expected to generate 2.23 times less return on investment than Mynaric AG. But when comparing it to its historical volatility, Cizzle Biotechnology Holdings is 1.47 times less risky than Mynaric AG. It trades about 0.08 of its potential returns per unit of risk. Mynaric AG is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  360.00  in Mynaric AG on September 2, 2024 and sell it today you would earn a total of  142.00  from holding Mynaric AG or generate 39.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.48%
ValuesDaily Returns

Cizzle Biotechnology Holdings  vs.  Mynaric AG

 Performance 
       Timeline  
Cizzle Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cizzle Biotechnology Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Cizzle Biotechnology exhibited solid returns over the last few months and may actually be approaching a breakup point.
Mynaric AG 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mynaric AG are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Mynaric AG unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cizzle Biotechnology and Mynaric AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cizzle Biotechnology and Mynaric AG

The main advantage of trading using opposite Cizzle Biotechnology and Mynaric AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cizzle Biotechnology position performs unexpectedly, Mynaric AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mynaric AG will offset losses from the drop in Mynaric AG's long position.
The idea behind Cizzle Biotechnology Holdings and Mynaric AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm